{"id":"https://openalex.org/W7220480355","doi":null,"title":"Analytical method development and validation of emtricitabine, bictegravir, tenofovir alafenamide by RP-HPLC","display_name":"Analytical method development and validation of emtricitabine, bictegravir, tenofovir alafenamide by RP-HPLC","alternate_titles":[],"publication_year":2020,"publication_date":"2020-10-16","ids":{"openalex":"https://openalex.org/W7220480355"},"language":"en","primary_location":{"id":"pmh:oai:ojs2.www.ijpir.com:article/160","doi":null,"is_oa":true,"landing_page_url":"https://www.ijpir.com/index.php/ijpir/article/view/160","pdf_url":"https://www.ijpir.com/index.php/ijpir/article/download/160/144","source":{"id":"https://openalex.org/S7407057146","display_name":"International Journal of Pharmacy and Industrial Research","issn_l":"2231-3648","issn":["2231-3648","2231-3656"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2231-3648","raw_type":"info:eu-repo/semantics/article"},"parent_works":[],"lineage":["https://openalex.org/W7220480355"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.ijpir.com/index.php/ijpir/article/download/160/144","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5157455107","display_name":"Asma Begum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Asma Begum","raw_affiliation_strings":["Department of Pharmaceutical Analysis, Shadan Women\u2019s College of Pharmacy, Khairatabad, Hyderabad,  Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Analysis, Shadan Women\u2019s College of Pharmacy, Khairatabad, Hyderabad,  Telangana, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017710583","display_name":"Ayesha Begum K","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ayesha Begum K","raw_affiliation_strings":["Department of Pharmaceutical Analysis, Shadan Women\u2019s College of Pharmacy, Khairatabad, Hyderabad,  Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Analysis, Shadan Women\u2019s College of Pharmacy, Khairatabad, Hyderabad,  Telangana, India","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5156642662","display_name":"P.Sandhya","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dr. P.Sandhya","raw_affiliation_strings":["Department of Pharmaceutical Analysis, Shadan Women\u2019s College of Pharmacy, Khairatabad, Hyderabad,  Telangana, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Analysis, Shadan Women\u2019s College of Pharmacy, Khairatabad, Hyderabad,  Telangana, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/emtricitabine","display_name":"emtricitabine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bictegravir","display_name":"bictegravir","score":1.0},{"id":"https://openalex.org/keywords/tenofovir-alafenamide","display_name":"tenofovir alafenamide","score":1.0},{"id":"https://openalex.org/keywords/antiretroviral-drugs","display_name":"antiretroviral drugs","score":0.8730000257492065},{"id":"https://openalex.org/keywords/rp-hplc-method-development","display_name":"RP-HPLC method development","score":0.7910000085830688},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.6940000057220459},{"id":"https://openalex.org/keywords/pharmaceutical-formulation-analysis","display_name":"pharmaceutical formulation analysis","score":0.6209999918937683},{"id":"https://openalex.org/keywords/drug-quantification","display_name":"pharmaceutical analysis","score":0.8389999866485596}],"concepts":[{"id":"https://openalex.org/C2911190787","wikidata":"https://www.wikidata.org/wiki/Q22075912","display_name":"Tenofovir alafenamide","level":5,"score":0.6140000224113464},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.4602000117301941},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.4442000091075897},{"id":"https://openalex.org/C2779344132","wikidata":"https://www.wikidata.org/wiki/Q155954","display_name":"Tenofovir","level":3,"score":0.4196999967098236},{"id":"https://openalex.org/C77170095","wikidata":"https://www.wikidata.org/wiki/Q1753188","display_name":"Linearity","level":2,"score":0.41119998693466187},{"id":"https://openalex.org/C77281830","wikidata":"https://www.wikidata.org/wiki/Q718608","display_name":"Dosage form","level":2,"score":0.39320001006126404},{"id":"https://openalex.org/C89838059","wikidata":"https://www.wikidata.org/wiki/Q623738","display_name":"Coefficient of variation","level":2,"score":0.387800008058548},{"id":"https://openalex.org/C2780092901","wikidata":"https://www.wikidata.org/wiki/Q3433612","display_name":"Correlation coefficient","level":2,"score":0.3652999997138977},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3343000113964081},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.3151000142097473},{"id":"https://openalex.org/C9893847","wikidata":"https://www.wikidata.org/wiki/Q1425625","display_name":"Reproducibility","level":2,"score":0.31290000677108765},{"id":"https://openalex.org/C2779502633","wikidata":"https://www.wikidata.org/wiki/Q937224","display_name":"Dolutegravir","level":5,"score":0.3075999915599823},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.28290000557899475}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:ojs2.www.ijpir.com:article/160","doi":null,"is_oa":true,"landing_page_url":"https://www.ijpir.com/index.php/ijpir/article/view/160","pdf_url":"https://www.ijpir.com/index.php/ijpir/article/download/160/144","source":{"id":"https://openalex.org/S7407057146","display_name":"International Journal of Pharmacy and Industrial Research","issn_l":"2231-3648","issn":["2231-3648","2231-3656"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2231-3648","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:ojs2.www.ijpir.com:article/160","doi":null,"is_oa":true,"landing_page_url":"https://www.ijpir.com/index.php/ijpir/article/view/160","pdf_url":"https://www.ijpir.com/index.php/ijpir/article/download/160/144","source":{"id":"https://openalex.org/S7407057146","display_name":"International Journal of Pharmacy and Industrial Research","issn_l":"2231-3648","issn":["2231-3648","2231-3656"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2231-3648","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"score":0.4043000042438507,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7220480355.pdf","grobid_xml":"https://content.openalex.org/works/W7220480355.grobid-xml"},"referenced_works_count":15,"referenced_works":["https://openalex.org/W1969729212","https://openalex.org/W1994401508","https://openalex.org/W1998150497","https://openalex.org/W2121858968","https://openalex.org/W2183163677","https://openalex.org/W2294340949","https://openalex.org/W2331785597","https://openalex.org/W2489011082","https://openalex.org/W2523305619","https://openalex.org/W2586083164","https://openalex.org/W2737982238","https://openalex.org/W2767545375","https://openalex.org/W2901456774","https://openalex.org/W4300658851","https://openalex.org/W7219368079"],"related_works":["https://openalex.org/W7219368079","https://openalex.org/W2982978742","https://openalex.org/W4403225180","https://openalex.org/W7216055411","https://openalex.org/W3196974939","https://openalex.org/W7219239363","https://openalex.org/W4388205147","https://openalex.org/W2901206341","https://openalex.org/W4200587923","https://openalex.org/W7220572034"],"abstract_inverted_index":{"A":[0],"simple":[1],"and":[2,11,21,53,92,98,132],"precise":[3],"method":[4,15,124],"was":[5,16,25,55,78,113],"developed":[6],"for":[7,85,88,95],"estimating":[8],"Emtricitabine,":[9,83,96,130],"Bictegravir":[10,97,131],"Tenofovir":[12,89,99,133],"Alafenamide.":[13,90],"The":[14,23,72],"found":[17,79],"to":[18,63,80,128],"be":[19,81,126],"specific":[20],"precise.":[22],"separation":[24],"attained":[26],"on":[27],"Symmetry":[28],"C18":[29],"(150":[30],"\u00d7":[31],"4.5mm,":[32],"5\u00b5m)column":[33],"with":[34,68],"Water":[35],":":[36,38],"Acetonitrile":[37],"Methanol":[39],"(15:35:50)":[40],"%":[41],"v/v":[42],"as":[43],"mobile":[44],"phase":[45],"at":[46],"a":[47],"flow":[48],"rate":[49],"of":[50,61,65],"1.0":[51],"ml/min":[52],"linearity":[54],"achieved":[56],"in":[57],"the":[58,76,103,107,110,119],"concentration":[59,67],"range":[60],"50%":[62],"150%":[64],"standard":[66],"correlation":[69],"coefficient":[70],"0.99.":[71],"percent":[73],"recovery":[74],"from":[75],"assay":[77],"100.80%for":[82],"100.34%":[84],"Bictegravirand":[86],"100.64%":[87],"Specificity":[91],"precision":[93],"studies":[94],"Alafenamide":[100],"were":[101],"within":[102],"acceptable":[104],"range.":[105],"From":[106],"stability":[108],"studies,":[109],"percentage":[111],"variation":[112],"less":[114],"than":[115],"10.0%":[116],"which":[117],"is":[118],"desired":[120],"criteria.":[121],"Therefore,":[122],"this":[123],"can":[125],"adopted":[127],"estimate":[129],"Alafenamidein":[134],"other":[135],"pharmaceutical":[136],"formulations.":[137]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7220480355","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2026-10-06T00:00:00"}
